162 related articles for article (PubMed ID: 11787071)
21. Analysis of the alpha4beta1 integrin-osteopontin interaction.
Barry ST; Ludbrook SB; Murrison E; Horgan CM
Exp Cell Res; 2000 Aug; 258(2):342-51. PubMed ID: 10896785
[TBL] [Abstract][Full Text] [Related]
22. The carboxyl-terminal fragment of osteopontin suppresses arginine-glycine-asparatic acid-dependent cell adhesion.
Takahashi K; Takahashi F; Tanabe KK; Takahashi H; Fukuchi Y
Biochem Mol Biol Int; 1998 Dec; 46(6):1081-92. PubMed ID: 9891840
[TBL] [Abstract][Full Text] [Related]
23. Evidence that a non-RGD domain in rat osteopontin is involved in cell attachment.
van Dijk S; D'Errico JA; Somerman MJ; Farach-Carson MC; Butler WT
J Bone Miner Res; 1993 Dec; 8(12):1499-506. PubMed ID: 8304052
[TBL] [Abstract][Full Text] [Related]
24. Characterization of anti-osteopontin monoclonal antibodies: Binding sensitivity to post-translational modifications.
Kazanecki CC; Kowalski AJ; Ding T; Rittling SR; Denhardt DT
J Cell Biochem; 2007 Nov; 102(4):925-35. PubMed ID: 17786932
[TBL] [Abstract][Full Text] [Related]
25. Ca2+ suppresses cell adhesion to osteopontin by attenuating binding affinity for integrin alpha v beta 3.
Hu DD; Hoyer JR; Smith JW
J Biol Chem; 1995 Apr; 270(17):9917-25. PubMed ID: 7537271
[TBL] [Abstract][Full Text] [Related]
26. Proteomic analysis and immunodetection of the bovine milk osteopontin isoforms.
Bissonnette N; Dudemaine PL; Thibault C; Robitaille G
J Dairy Sci; 2012 Feb; 95(2):567-79. PubMed ID: 22281321
[TBL] [Abstract][Full Text] [Related]
27. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin.
Yokosaki Y; Tanaka K; Higashikawa F; Yamashita K; Eboshida A
Matrix Biol; 2005 Sep; 24(6):418-27. PubMed ID: 16005200
[TBL] [Abstract][Full Text] [Related]
28. Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D.
Christensen B; Schack L; Kläning E; Sørensen ES
J Biol Chem; 2010 Mar; 285(11):7929-37. PubMed ID: 20071328
[TBL] [Abstract][Full Text] [Related]
29. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis.
Yamamoto N; Sakai F; Kon S; Morimoto J; Kimura C; Yamazaki H; Okazaki I; Seki N; Fujii T; Uede T
J Clin Invest; 2003 Jul; 112(2):181-8. PubMed ID: 12865407
[TBL] [Abstract][Full Text] [Related]
30. Autoantibodies to osteopontin in patients with osteoarthritis and rheumatoid arthritis.
Sakata M; Tsuruha JI; Masuko-Hongo K; Nakamura H; Matsui T; Sudo A; Nishioka K; Kato T
J Rheumatol; 2001 Jul; 28(7):1492-5. PubMed ID: 11469452
[TBL] [Abstract][Full Text] [Related]
31. Osteopontin is highly susceptible to cleavage in bovine milk and the proteolytic fragments bind the αVβ₃-integrin receptor.
Christensen B; Sørensen ES
J Dairy Sci; 2014; 97(1):136-46. PubMed ID: 24268404
[TBL] [Abstract][Full Text] [Related]
32. Fine epitope mapping of monoclonal antibody 5F1 reveals anticatalytic activity toward the N domain of human angiotensin-converting enzyme.
Danilov SM; Watermeyer JM; Balyasnikova IV; Gordon K; Kugaevskaya EV; Elisseeva YE; Albrecht RF; Sturrock ED
Biochemistry; 2007 Aug; 46(31):9019-31. PubMed ID: 17630779
[TBL] [Abstract][Full Text] [Related]
33. Methods to Investigate Thrombin Cleavage of Osteopontin (OPN).
Zhao L; Leung LL; Morser J
Methods Mol Biol; 2024; 2747():95-117. PubMed ID: 38038935
[TBL] [Abstract][Full Text] [Related]
34. Improved immunohistochemical staining of osteopontin (OPN) in paraffin-embedded archival bone specimens following antigen retrieval: anti-human OPN antibody recognizes multiple molecular forms.
Devoll RE; Pinero GJ; Appelbaum ER; Dul E; Troncoso P; Butler WT; Farach-Carson MC
Calcif Tissue Int; 1997 Apr; 60(4):380-6. PubMed ID: 9075637
[TBL] [Abstract][Full Text] [Related]
35. Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer.
Shojaei F; Scott N; Kang X; Lappin PB; Fitzgerald AA; Karlicek S; Simmons BH; Wu A; Lee JH; Bergqvist S; Kraynov E
J Exp Clin Cancer Res; 2012 Mar; 31(1):26. PubMed ID: 22444159
[TBL] [Abstract][Full Text] [Related]
36. A regulated interaction between alpha5beta1 integrin and osteopontin.
Barry ST; Ludbrook SB; Murrison E; Horgan CM
Biochem Biophys Res Commun; 2000 Jan; 267(3):764-9. PubMed ID: 10673366
[TBL] [Abstract][Full Text] [Related]
37. Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by alpha9beta1 integrin.
Smith LL; Cheung HK; Ling LE; Chen J; Sheppard D; Pytela R; Giachelli CM
J Biol Chem; 1996 Nov; 271(45):28485-91. PubMed ID: 8910476
[TBL] [Abstract][Full Text] [Related]
38. Transforming JB6 cells exhibit enhanced integrin-mediated adhesion to osteopontin.
Chang PL; Chambers AF
J Cell Biochem; 2000 Apr; 78(1):8-23. PubMed ID: 10797562
[TBL] [Abstract][Full Text] [Related]
39. Structural requirements for alpha 9 beta 1-mediated adhesion and migration to thrombin-cleaved osteopontin.
Smith LL; Giachelli CM
Exp Cell Res; 1998 Jul; 242(1):351-60. PubMed ID: 9665832
[TBL] [Abstract][Full Text] [Related]
40. New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2.
Botquin V; Hess H; Fuhrmann G; Anastassiadis C; Gross MK; Vriend G; Schöler HR
Genes Dev; 1998 Jul; 12(13):2073-90. PubMed ID: 9649510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
